REQUEST A DEMO
Total
USD $0.00
Search more companies

Chongqing Genrix Biopharmaceutical Co., Ltd. (重庆智翔金泰生物制药股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Chongqing Genrix Biopharmaceutical Co., Ltd. Profile Updated: March 29, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Chongqing Genrix Biopharmaceutical Co., Ltd. (重庆智翔金泰生物制药股份有限公司) is based in China. The head office is in Chongqing. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was first established on October 20, 2015. It currently has a total number of 392 (2022) employees. There was a net sales revenue increase of 1562.05% reported in Chongqing Genrix Biopharmaceutical Co., Ltd. (重庆智翔金泰生物制药股份有限公司)’s latest financial highlights for Q3C2025. Over the same period, its total assets decreased by 7.18%. The net profit margin of Chongqing Genrix Biopharmaceutical Co., Ltd. (重庆智翔金泰生物制药股份有限公司) increased by 4214.75% in 2025.

Headquarters
No. 699, Maliu Avenue, Banan District, Chongqing
Chongqing; Chongqing; Postal Code: 401338

Contact Details: Purchase the Chongqing Genrix Biopharmaceutical Co., Ltd. (重庆智翔金泰生物制药股份有限公司) report to view the information.

Website: http://www.genrixbio.com

Basic Information
Total Employees:
Purchase the Chongqing Genrix Biopharmaceutical Co., Ltd. (重庆智翔金泰生物制药股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Chongqing Genrix Biopharmaceutical Co., Ltd. (重庆智翔金泰生物制药股份有限公司) report to view the information.
Registered Capital:
Purchase the Chongqing Genrix Biopharmaceutical Co., Ltd. (重庆智翔金泰生物制药股份有限公司) report to view the information.
Financial Auditors:
Purchase the Chongqing Genrix Biopharmaceutical Co., Ltd. (重庆智翔金泰生物制药股份有限公司) report to view the information.
Incorporation Date:
October 20, 2015
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
54.54%
Purchase this report to view the information.
3.97%
Purchase this report to view the information.
3.13%
Purchase this report to view the information.
2.45%
Purchase this report to view the information.
1.7%
Subsidiaries
Beijing Zhirenmeibo Biotechnology Co., Ltd.
100%
Zhixiang (Shanghai) Pharmaceutical Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Chongqing Genrix Biopharmaceutical Co., Ltd. (重庆智翔金泰生物制药股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
1562.05%
Total Operating Revenue
1496.02%
Operating Profit
40.29%
Net Profit/Loss for the Period
39.12%
Total Assets
-7.18%
Total Equity
-24.03%
Operating Profit Margin
4213.68%
Net Profit Margin
4214.75%
Return on Equity (ROE)
4.62%
Debt / Equity
18182%
Quick Ratio
-11252.05%
Cash Ratio
-10.63%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?